Evidence map›Paper›PMID 30505982›Full record

ArticleNanoImpact2018

An inventory of ready-to-use and publicly available tools for the safety assessment of nanomaterials.

A Paula K Jantunen, Stefania Gottardo, Kirsten Rasmussen, Hugues P Crutzen

Abstract read
In one paragraph

Article in NanoImpact, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Insights into Nanopesticides for Ticks: The Superbugs of Livestock.Oxidative medicine and cellular longevity · 2022
    Review
  7. Features, applications, and sustainability of lipid nanoparticles in cosmeceuticals.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2022
    Review
  8. Safe-by-Design in Engineering: An Overview and Comparative Analysis of Engineering Disciplines.International journal of environmental research and public health · 2021
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

A Paula K JantunenEuropean Commission, Joint Research Centre, Via E. Fermi 2479, I-21027 Ispra, Italy.
Stefania GottardoEuropean Commission, Joint Research Centre, Via E. Fermi 2479, I-21027 Ispra, Italy.
Kirsten RasmussenEuropean Commission, Joint Research Centre, Via E. Fermi 2479, I-21027 Ispra, Italy.
Hugues P CrutzenEuropean Commission, Joint Research Centre, Via E. Fermi 2479, I-21027 Ispra, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Legislation addressing environmental, health and safety aspects of nanomaterials in consumer products and ensuring their safe use is being continuously updated in the European Union and globally. This leads to a growing need for tools to implement this developing legislation. A freely accessible inventory of ready-to-use and publicly available tools that together cover the tasks within a nanomaterial safety assessment process was built in the presented work. This inventory is a unique metadata set in Excel® format: the 'NANoREG Toolbox', which assembles information needed for selecting and accessing instruments that meet specific goals. The recorded tools are categorised according to their purpose, type and regulatory status. The Toolbox covers an unprecedented and broad range of over 500 current tools, developed in Europe and beyond. While NANoREG focussed on safety assessment under the EU Regulation on Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), the instruments in the Toolbox are relevant and useful for nanomaterial safety assessments worldwide.

Indexed as

InventoryNanomaterialRegulationSafety assessmentTools

Identifiers

PMID30505982
PMCPMC6255795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.